Literature DB >> 10974610

Olanzapine and obsessive-compulsive symptoms.

L Lykouras1, I M Zervas, R Gournellis, M Malliori, A Rabavilas.   

Abstract

Clozapine and risperidone have been implicated in the development of obsessive-compulsive symptoms. We present three cases in which olanzapine caused a significant exacerbation of obsessive-compulsive symptoms in schizophrenia (two cases) and obsessive-compulsive disorder (one case).

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10974610     DOI： 10.1016/s0924-977x(00)00096-1

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN： 0924-977X            Impact factor:   4.600


  6 in total

Review 1.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

2.  Interventions for obsessive compulsive symptoms in people with schizophrenia.

Authors:  Mohan Raj; Saeed Farooq
Journal:  Cochrane Database Syst Rev       Date:  2005

Review 3.  Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Authors:  Michael Poyurovsky; Abraham Weizman; Ronit Weizman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?

Authors:  Alexandra Bottas; Robert G Cooke; Margaret A Richter
Journal:  J Psychiatry Neurosci       Date:  2005-05       Impact factor: 6.186

5.  Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study.

Authors:  Martin Cederlöf; Paul Lichtenstein; Henrik Larsson; Marcus Boman; Christian Rück; Mikael Landén; David Mataix-Cols
Journal:  Schizophr Bull       Date:  2014-12-15       Impact factor: 9.306

6.  Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder.

Authors:  N Konuk; I O Tekin; U Ozturk; L Atik; N Atasoy; S Bektas; A Erdogan
Journal:  Mediators Inflamm       Date:  2007-02-27       Impact factor: 4.711
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.